Evidence map›Paper›PMID 31068477›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Endometrial carcinoma may favor partial, but not complete, loss of the TGF-β signaling pathway.

Ji-Long Liu, Jia-Peng He, Can Zhu, Hao-Zhuang Cheng

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. miRNAs in neurodegenerative diseases: from target screening to precision therapy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  3. Review
  4. Review
  5. Role and Dysregulation of miRNA in Patients with Parkinson's Disease.International journal of molecular sciences · 2022
    Article
  6. Article
  7. Article
  8. Reply to Liu et al.: ALK5-mediated tumor suppressor signaling through SMAD2 and SMAD3 in the uterus.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Ji-Long LiuCollege of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China jilongliu@scau.edu.cn.ORCID 0000-0002-6948-2576
Jia-Peng HeCollege of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
Can ZhuCollege of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
Hao-Zhuang ChengCollege of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Endometrial NeoplasmsInfertilityAnimalsFemaleHumansMiceSignal TransductionSmad2 ProteinSmad3 ProteinTransforming Growth Factor betaSmad2 ProteinSMAD2 protein, humanSmad3 ProteinSMAD3 protein, humanTransforming Growth Factor beta

Identifiers

PMID31068477
PMCPMC6511018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.